D. E. Müller‐Wiefel

996 total citations
39 papers, 677 citations indexed

About

D. E. Müller‐Wiefel is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D. E. Müller‐Wiefel has authored 39 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 11 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D. E. Müller‐Wiefel's work include Renal Diseases and Glomerulopathies (7 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Clostridium difficile and Clostridium perfringens research (6 papers). D. E. Müller‐Wiefel is often cited by papers focused on Renal Diseases and Glomerulopathies (7 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Clostridium difficile and Clostridium perfringens research (6 papers). D. E. Müller‐Wiefel collaborates with scholars based in Germany, United States and Canada. D. E. Müller‐Wiefel's co-authors include Markus J. Kemper, Martin Bitzan, Kerstin U. Ludwig, Markus J. Kemper, S. Conrad, Jonas Burén, H. König, Otto Mehls, Franz Schaefer and K Schärer and has published in prestigious journals such as The Journal of Infectious Diseases, Bone and Nephrology Dialysis Transplantation.

In The Last Decade

D. E. Müller‐Wiefel

39 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. E. Müller‐Wiefel Germany 14 256 182 156 149 124 39 677
Thérèsa Kwon France 19 525 2.1× 132 0.7× 125 0.8× 121 0.8× 84 0.7× 49 1.1k
Marvin Forland United States 17 174 0.7× 100 0.5× 76 0.5× 109 0.7× 125 1.0× 33 857
Mini Michael United States 12 229 0.9× 46 0.3× 44 0.3× 159 1.1× 89 0.7× 32 612
Amy Staples United States 9 274 1.1× 122 0.7× 120 0.8× 98 0.7× 44 0.4× 11 639
Savita Saini India 13 178 0.7× 47 0.3× 79 0.5× 82 0.6× 37 0.3× 29 493
Rebecca L. Ruebner United States 14 207 0.8× 79 0.4× 76 0.5× 75 0.5× 46 0.4× 34 735
Meral Gültekin Türkiye 16 44 0.2× 36 0.2× 91 0.6× 57 0.4× 89 0.7× 63 652
C. L. Jones Australia 11 73 0.3× 56 0.3× 54 0.3× 43 0.3× 128 1.0× 20 401
Prayong Vachvanichsanong Thailand 17 287 1.1× 16 0.1× 85 0.5× 139 0.9× 102 0.8× 58 838
A. Debure France 12 90 0.4× 27 0.1× 66 0.4× 72 0.5× 57 0.5× 34 736

Countries citing papers authored by D. E. Müller‐Wiefel

Since Specialization
Citations

This map shows the geographic impact of D. E. Müller‐Wiefel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. E. Müller‐Wiefel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. E. Müller‐Wiefel more than expected).

Fields of papers citing papers by D. E. Müller‐Wiefel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. E. Müller‐Wiefel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. E. Müller‐Wiefel. The network helps show where D. E. Müller‐Wiefel may publish in the future.

Co-authorship network of co-authors of D. E. Müller‐Wiefel

This figure shows the co-authorship network connecting the top 25 collaborators of D. E. Müller‐Wiefel. A scholar is included among the top collaborators of D. E. Müller‐Wiefel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. E. Müller‐Wiefel. D. E. Müller‐Wiefel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nielsen, Stine, Christina Frank, Angelika Fruth, et al.. (2011). Desperately Seeking Diarrhoea: Outbreak of Haemolytic Uraemic Syndrome Caused by Emerging Sorbitol‐Fermenting Shiga Toxin‐Producing Escherichia coli O157:H‐, Germany, 2009. Zoonoses and Public Health. 58(8). 567–572. 11 indexed citations
2.
Müller‐Wiefel, D. E., et al.. (2010). Treatment of growth failure with growth hormone in children with chronic kidney disease: an open-label long-term study. Clinical Nephrology. 74(8). 97–105. 7 indexed citations
3.
Müller‐Berghaus, Jan, Markus J. Kemper, Bernd Höppe, et al.. (2008). The clinical course of steroid-sensitive childhood nephrotic syndrome is associated with a functional IL12B promoter polymorphism. Nephrology Dialysis Transplantation. 23(12). 3841–3844. 9 indexed citations
4.
Wigger, Marianne, Ulrike John, Simone Wygoda, et al.. (2008). Estimated one‐yr glomerular filtration rate is an excellent predictor of long‐term graft survival in pediatric first kidney transplants. Pediatric Transplantation. 13(3). 365–370. 15 indexed citations
5.
Kemper, Markus J., Oliver Amon, Kirsten Timmermann, H. Altrogge, & D. E. Müller‐Wiefel. (2008). Die Behandlung des häufig rezidivierenden steroidsensiblen idiopathischen nephrotischen Syndroms im Kindesalter mit Levamisol. DMW - Deutsche Medizinische Wochenschrift. 123(9). 239–243. 6 indexed citations
6.
John, Ulrich, Anne Schulze Everding, Eberhard Kuwertz-Bröking, et al.. (2006). High prevalence of febrile urinary tract infections after paediatric renal transplantation. Nephrology Dialysis Transplantation. 21(11). 3269–3274. 47 indexed citations
7.
Kemper, Markus J., et al.. (2003). Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome. Clinical Nephrology. 60(10). 242–247. 75 indexed citations
8.
Tenbrock, Klaus, Markus J. Kemper, Jutta Gellermann, et al.. (2002). Type I IgE receptor, interleukin 4 receptor and interleukin 13 polymorphisms in children with nephrotic syndrome. Clinical Science. 102(5). 507–512. 28 indexed citations
9.
Querfeld, Uwe, Bernd Kohl, W. Fiehn, et al.. (1999). Probucol for treatment of hyperlipidemia in persistent childhood nephrotic syndrome. Pediatric Nephrology. 13(1). 7–12. 10 indexed citations
10.
Ludwig, Kerstin U. & D. E. Müller‐Wiefel. (1998). Pathomechanisms in the haemolytic-uraemic syndrome. Nephrology Dialysis Transplantation. 13(1). 23–27. 7 indexed citations
11.
Kemper, Markus J., et al.. (1997). IgG2 deficiency in uremic children is not restricted to peritoneal dialysis treatment. Pediatric Nephrology. 11(6). 684–686. 7 indexed citations
12.
Kemper, Markus J., S. Conrad, & D. E. Müller‐Wiefel. (1997). Primary hyperoxaluria type 2. European Journal of Pediatrics. 156(7). 509–512. 57 indexed citations
13.
Kemper, Markus J. & D. E. Müller‐Wiefel. (1996). Nephrocalcinosis in a patient with primary hyperoxaluria type 2. Pediatric Nephrology. 10(4). 442–444. 13 indexed citations
14.
Kemper, Markus J., et al.. (1996). Effective treatment of acute hyperkalaemia in childhood by short-term infusion of salbutamol. European Journal of Pediatrics. 155(6). 495–497. 10 indexed citations
15.
Kemper, Markus J., et al.. (1996). Hyperkalemia: therapeutic options in acute and chronic renal failure.. PubMed. 46(1). 67–9. 15 indexed citations
16.
17.
Schärer, K, Ulrike M. Reiss, Otto Mehls, et al.. (1993). Changning pattern of chronic renal failure and renal replacement therapy in children and adolescents: a 20-year single centre study. European Journal of Pediatrics. 152(2). 166–171. 10 indexed citations
18.
Bitzan, Martin, et al.. (1993). Differences in verotoxin neutralizing activity of therapeutic immunoglobulins and sera from healthy controls. Infection. 21(3). 140–145. 25 indexed citations
19.
Ruder, H., J. Strehlau, Franz Schaefer, et al.. (1989). Low-dose cyclosporin A therapy in cadaver renal transplantation in children. Transplant International. 2(1). 203–208. 4 indexed citations
20.
Stein, Laszlo, et al.. (1984). Psychosocial adaptation of children and their parents to hospital and home hemodialysis.. PubMed. 5(1). 45–52. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thérèsa Kwon Breakdown of academic impact, for papers by Marvin Forland Breakdown of academic impact, for papers by Mini Michael Breakdown of academic impact, for papers by Amy Staples Breakdown of academic impact, for papers by Savita Saini Breakdown of academic impact, for papers by Rebecca L. Ruebner Breakdown of academic impact, for papers by Meral Gültekin Breakdown of academic impact, for papers by C. L. Jones Breakdown of academic impact, for papers by Prayong Vachvanichsanong Breakdown of academic impact, for papers by A. Debure
Rankless by CCL
2026